As Wall Street’s broader market averages continue to decline on Tuesday, following Monday’s significant sell-off, the idea of ...

Analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of Elevance Health in a report released on Thursday, February 27th. Zacks Research analyst K. Dey now forecasts that the ...

Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a ...

For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

With a market cap of $90.6 billion, Elevance Health, Inc. (ELV ... ELV is trading below the mean price target of $485.13. The Street-high price target of $625 implies a potential upside of ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

Special Needs Plans boosted a sluggish Medicare Advantage market during the annual enrollment period for 2025, a Modern ...

UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records ...